Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sano Genetics logo — Accelerating the world's transition to precision medicine.

Sano Genetics

Accelerating the world's transition to precision medicine.

Founded 2016 United Kingdom Cambridge, United Kingdom 50 employees Unknown Total: $20.86M Biopharma, Biotechnology +2

General Information

Company Name Sano Genetics
Founded Year 2016
Location United Kingdom Cambridge, United Kingdom +1
Employees 50
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Unknown
Social

Get notified when Sano Genetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Aug 28, 2026

Sano supported an ultra-rare program, demonstrating the positive impact of keeping patients engaged after a study.

Event Participation Aug 18, 2026

Sano Genetics will be participating as an exhibitor and speaker at DPharm in Boston next month, inviting attendees to visit Booths #307 and #308 and attend their session.

New Partnership Aug 18, 2026

Sano Genetics announced a strategic partnership with Labcorp to enhance patient access in rare disease trials by combining real-world data with patient engagement infrastructure.

Market Expansion Aug 17, 2026

Sano Genetics announced a geographic expansion, with co-founder Charlotte Guzzo relocating to San Francisco to focus on the West Coast market.

Get alerts when Sano Genetics shows new signals

AI Insight

Bounce Watch AI
2 months ago

Sano Genetics has demonstrated significant operational success, notably recruiting nearly 1,000 participants for its LiveWell study from a single NHS site in under a year, strongly validating its patient enrollment platform. This traction is complemented by a recent Innovate UK grant and a presentation at the EASL Congress, underscoring both scientific validation and increasing industry recognition. These developments highlight their growing capabilities and strategic positioning in precision medicine.

Signal Types
Funding Traction Event
Strategic Labels
Patient Recruitment Success Clinical Validation Precision Medicine Growth
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: Health Tech VCs — Growth Stage, Precision Medicine Investors

About Sano Genetics

Sano Genetics, founded in 2016, is positioned at the cutting edge of the Biopharma and Life Sciences industries. Headquartered in the United Kingdom, the company aims to revolutionize health care by "accelerating the world's transition to precision medicine." Their innovative platform combines genetic testing, recruitment, and long-term engagement to streamline operations for precision medicine teams.

Sano Genetics' multi-functional approach not only accelerates patient enrollment but also simplifies complex processes, ultimately driving breakthroughs in patient care. Their recent investment from PharmStars, as of 01 July 2024, underscores investor confidence in their mission and potential. With a focus on biotechnology and health care, Sano Genetics is well-positioned to impact the future of medicine substantially by supporting the growing demand for personalized treatment solutions.

Taxonomy: Precision Medicine, Genetic Testing, Health Technology, Personalized Medicine, Research Studies, Genetic Data Contribution, Medical Research, Patient Engagement, Data-Driven Healthcare, Clinical Trials, Genomics, Health Data Analytics, Patient Recruitment, Scientific Research

Services & Products

Recruitment support
Protocol development
DNA testing
Electronic medical record retrieval
Patient engagement
Prescreening and digital consent

Target Customers

Life science companies Research initiatives Sponsors Contract Research Organizations (CROs) Research sites

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Unknown •••••• 1
Investor
01 Jul 2024
Early VC •••••• 1 •••• •••• 01 Jan 2024
Grant •••••• - 01 Aug 2023
Series A •••••• 10
Investor Investor Investor
•••• •••• 		01 Feb 2022
Early VC •••••• 4
Investor Investor Investor Investor
01 Jan 2021

View All 11 Funding Rounds

Latest News

View All
Founders of Wise and Skype raise $436 million to build tech giants in Europe — Cnbc
Founders of Wise and Skype raise $436 million to build tech giants in Europe
Cnbc Jan 23, 2024
Plural launches a new €400M fund to back world-changing startups — Tech
Plural launches a new €400M fund to back world-changing startups
Tech Jan 23, 2024
Sano Genetics raises $11.4M to advance precision medicine clinical trials — Tech
Sano Genetics raises $11.4M to advance precision medicine clinical trials
Tech Jan 23, 2024
Founder-led deep tech investor Plural launches €400M fund — Thenextweb
Founder-led deep tech investor Plural launches €400M fund
Thenextweb Jan 23, 2024
Early-stage UK VC Episode 1 closes $95M third fund — Techcrunch
Early-stage UK VC Episode 1 closes $95M third fund
Techcrunch Feb 07, 2024
Brunch with Plural and HelixNano’s Carina Namih: I needed to go to Silicon Valley to find VCs who co... — Sifted
Brunch with Plural and HelixNano’s Carina Namih: I needed to go to Silicon Valley to find VCs who could ‘match my ambition’
Sifted Apr 26, 2024

Sano Genetics Alternatives & Competitors

Sano Genetics vs
Function
Function United States

Personalized functional genomics transforming the future of cancer

Series A
7 employees
Biotechnology, Health and Wellness
Compare Sano Genetics vs Function
Sano Genetics vs
Hygea Precision Medicine Inc.
Hygea Precision Medicine Inc. United States

Genes for Life®

Debt Financing
1 employees
Health Care
Compare Sano Genetics vs Hygea Precision Medicine Inc.
Sano Genetics vs
Artisan Biomed
Artisan Biomed South Africa

Unraveling the African Genome to transform health care

1 employees
Biotechnology, Health and Wellness
Compare Sano Genetics vs Artisan Biomed

FAQ About Sano Genetics

Accelerating the world's transition to precision medicine.
Sano Genetics was founded in 2016.
Sano Genetics is headquartered in Cambridge, United Kingdom.
Sano Genetics operates in the following industries: Biopharma, Biotechnology, Health Care, Life Sciences.
Sano Genetics has approximately 50 employees.
Sano Genetics has completed 11 funding rounds, raising a total of $20.86M. The latest funding stage is Unknown.
Sano Genetics offers: Recruitment support, Protocol development, DNA testing, Electronic medical record retrieval, Patient engagement, Prescreening and digital consent.
Top alternatives and competitors to Sano Genetics include Function, Hygea Precision Medicine Inc., Artisan Biomed, Rx-Precision, Inc., OutSee. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sano Genetics and Function are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sano Genetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy